Genomate Health Taps Genomics Leader Nabil Hafez as CEO to Drive U.S. Launch and Global Expansion

Cambridge, MA, May 5, 2025 (ACCESS Newswire) -- Genomate Health has appointed genomics veteran Nabil Hafez as CEO to lead its commercial expansion and global scaling. The company’s computational platform for Digital Drug Assignment supports oncologists in selecting personalized cancer treatments. Founder Dr. Istvan Petak remains as CSO, while Hafez’s leadership marks a strategic shift toward product launch and broader clinical adoption.

Read full article here.